Anti-malarial Drugs Market to Surpass US$ 1,183.0 Million by 2027
The Global Anti-malarial Drugs Market, by Drug Class (Aminoquinolines, Quinoline-methanol (4-quinolinemethanols), Cinchona Alkaloids, Biguanides, Sulfonamides and Sulfones, and Others), by Route of Administration (Oral and Injectable), by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 839.1 million in 2019 and is expected to exhibit a CAGR of 4.4% during the forecast period (2019-2027), as highlighted in a new report published by Coherent Market Insights.Request Sample Report + All Related Graphs & Charts @ https://www.coherentmarketinsights.com/insight/request-sample/3726
The increasing number of regulatory approvals and launches of anti-malaria drugs is expected to propel growth of the global anti-malarial drugs market over the forecast period. For instance, in July 2018, GSK and Medicines for Malaria Venture (MMV) received the U.S. FDA approval for Krintafel (tafenoquine), a first single dose medicine to prevent the relapse of P. vivax malaria marks. Moreover, in July 2017, Cipla and Medicines for Malaria Venture (MMV) launched Artesunate Rectocaps/Rectal Artesunate Suppositories (RAS), a drug used for the treatment of severe malaria in young children.
Launching of anti-malaria drugs in the malaria affected areas such as African countries such as Uganda and other South-east Asian countries is expected to drive growth of the anti-malarial drugs market. For instance, in April 2019, Shin Poong Pharmaceutical Co.Ltd, South Korea, and Medicines for Malaria Venture (MMV) launched Pyramax, an anti-malarial drug combination of pyronardine and artesunate, in Uganada.
Moreover, in December 2014, Ranbaxy Laboratories Limited launched Synriam, a new anti-malarial drug, in 7 African countries including Nigeria, Uganda, Senegal, Cameroon, Guinea, Kenya, and Ivory Coast. Moreover, in April 2012, the drug was approved by the Drug Controller General of India (DCGI) for marketing in India.
Major players operating in the global anti-malarial drugs market include Ipca Laboratories Ltd., Zydus Cadila, Merck KGaA, Pfizer, GlaxoSmithKline Plc., Cipla Ltd, Ranbaxy Laboratories, Novartis AG, Alvizia Health Care, Bayer AG, and Roche Inc
Request Sample Report @ https://www.coherentmarketinsights.com/insight/request-sample/3726
Coherent Market Insights 1001 4th Ave,
#3200 Seattle, WA 98154,U.S.
Phone: US +1-206-701-6702/UK +44-020 8133 4027
Email: sales@coherentmarketinsights.com
About Author:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Anti-malarial Drugs Market to Surpass US$ 1,183.0 Million by 2027 here
News-ID: 2108362 • Views: …
More Releases from Coherent Market Insights
Board Packaging Market Analysis: Insights into Market Dynamics and Future Growth …
The latest report published by Coherent Market Insights highlights the growth prospects of the Board Packaging Market from 2024 to 2031. In-depth research on Industry Size, Share, Business Analysis, Growth Factors, and Regional Forecast. The market report gives a purposeful depiction of the area by the practice for research, amalgamation, market size, overview, and review of data taken from various sources. The market study includes information on market factors such…
Tankless Water Heater Market Analysis: Growth Factors, Opportunities, Challenges …
The latest report published by Coherent Market Insights highlights the growth prospects of the Tankless Water Heater Market from 2024 to 2031. In-depth research on Industry Size, Share, Business Analysis, Growth Factors, and Regional Forecast. The market report gives a purposeful depiction of the area by the practice for research, amalgamation, market size, overview, and review of data taken from various sources. The market study includes information on market factors…
Bispyribac Sodium Market Research Report: Industry Analysis, Size, Share, Growth …
The latest report published by Coherent Market Insights highlights the growth prospects of the Bispyribac Sodium Market from 2024 to 2031. In-depth research on Industry Size, Share, Business Analysis, Growth Factors, and Regional Forecast. The market report gives a purposeful depiction of the area by the practice for research, amalgamation, market size, overview, and review of data taken from various sources. The market study includes information on market factors such…
Electroplating Market: An Insightful Evaluation of Growth, Demand, Trends, and F …
The global electroplating market is US$ 18.40 Billion in 2022 and projected to reach US$ 27.3 Billion by the end of 2030, in terms of revenue, growing at CAGR of 5.06% during the forecast period (2023 to 2030).
The latest report published by Coherent Market Insights highlights the growth prospects of the Electroplating Market from 2024 to 2031. In-depth research on Industry Size, Share, Business Analysis, Growth Factors, and Regional Forecast.…
More Releases for Drug
Alcohol Testing And Drug Testing Equipment Market 2025 Segmentation, Application …
Market Study Report, LLC, has compiled an exhaustive research study of the ‘Alcohol Testing And Drug Testing Equipment market’, detailing every single market driver and intricately analyzing the business vertical. This ‘Alcohol Testing And Drug Testing Equipment market’ study will aid in seeking out new business opportunities and fine-tuning existing marketing strategies through insights regarding SWOT analysis, market valuation, competitive spectrum, regional share, and revenue predictions.
Alcohol abuse and drug…
How much Diabetes Drug Market Impact Worldwide Medical Drug Industry?
Diabetes Drug Market From an insight perspective, the market report focuses on various levels of analyses — industry analysis, market rank analysis, and company profiles, which together comprise and discuss basic views on the competitive landscape, high-growth regions, and countries as well as their respective regulatory policies, Types ,Applications and opportunities in the market.
Diabetes is a metabolic disorder in which the body glucose level is elevated. There are two types of diabetes…
Hepatitis Drug Market Hepatitis Drug Clinical Pipeline Report 2023
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Introduction to Hepatitis Disease
1.1 Prologue
1.1.1 History of Hepatitis
1.1.2 Causes of Hepatitis Disease
1.2 Types of Viruses which are Responsible for Hepatitis Disease
2. Global Prevalence of Hepatitis Infection
3. Available Drug Classes for Hepatitis Disease Treatment
3.1 Interferon Alfa Therapy
3.2 Protease Inhibitors Therapy
3.3 Polymerase…
Microcapsules Drug Delivery Market Microcapsules Drug Delivery Sales Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990
Report Table of Contents
1. Indispensable Advent of Microcapsules
1.1 Trajectory of Microencapsulation
1.2 Why and wherefores for Microencapsulation
2. Characterization of Microcapsules
2.1 Composition of Microcapsules
2.2 Parameters Influencing Microcapsules
3. Engineering Technology of Microcapsules
3.1 Physical Manufacturing Technologies
3.2 Physicochemical and Chemical Technologies
4. Applicability of Microcapsules
4.1 Microcapsules in Pharmaceuticals
4.2 Microcapsules in Nutraceuticals
…
AstraZeneca’s NMOSD Drug receives orphan drug designation
April 18, 2017 Orphan Drug
European Medicine Agency has Announced orphan drug designation for inebilizumab (earlier known as MEDI-551) developed by AstraZeneca PLC (AZN) for the treatment of neuromyelitis optica spectrum disorder (NMOSD). The drug has already received orphan drug status from US Food and Drug Administration (FDA). NMOSD, also called Devic’s disease, is a rare, autoimmune disorder of the central nervous system (CNS) that affects the functioning…
Drug Discovery Strategies, PBPK Modeling and Drug-Drug Interaction Explored and …
This year’s 12th annual ADMET conference and exhibition promises to deliver appearances from experienced pharmaceutical professionals from ADME and PK/PD organisations such as AbbVie, GSK, Roche and Bayer when it returns to London this June.
The carefully selected speaker line up will be addressing early ADME application strategies and discussing the latest technologically advanced screening and testing models along with exploring ADMET technologies which will identify properties of a drug…